Pricing Log in Create free account

Jasper Therapeutics, Inc. (JSPR) vs Pasithea Therapeutics Corp. (KTTA)

Jasper Therapeutics, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Pasithea Therapeutics Corp. is the larger, with a market value of $17.4M against $15.6M — 1.1× the size. Across the 9 metrics below, Pasithea Therapeutics Corp. leads on 5 and Jasper Therapeutics, Inc. on 4.

Valuation

Metric JSPR KTTA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 38.26 9.40
P/B 339.77 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.17 0.66
EV/Sales n/m (55.79) 9.02
Earnings yield (9.50%) (254.86%) (32.88%)
Free cash flow yield (12.55%) (94.76%) (23.13%)

Profitability

Metric JSPR KTTA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (255.05%) (65.49%) (51.96%)
Return on assets (109.05%) (61.97%) (46.06%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric JSPR KTTA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 19.22% 77.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JSPR KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.48 26.25 4.97
Net debt to EBITDA 0.35 2.74 1.01

Dividend

Metric JSPR KTTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JSPR KTTA Biotechnology median
Market cap 15.62m 17.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack